Interview with Children’s Hospital of Philadelphia

29/04/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time, Carol Kneibb and Ryan Morlen from Children’s Hospital of Philadelphia talk about their experiences and thoughts on HLA laboratory activities. We hope...

NGS Accreditation with ASHI Standards at the ASHI Annual Meeting 2016

23/09/2016

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in four oral presentations and five poster presentations produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in St Louis, MO. Additionally, Omixon’s Lunch Symposium on Thursday...

Omixon Announce Dimitri Monos as Chair of its Scientific Advisory Board

25/02/2016

Omixon announced today that Dr. Dimitri Monos, Director of the Immunogenetics Laboratory of The Children’s Hospital of Philadelphia (CHOP) and Professor of Pathology and Laboratory Medicine at Perelman School of Medicine of the University of Pennsylvania, will join their team as Chair of the company’s Scientific Advisory Board. Professor...

Omixon Upgrade Holotype HLA to 7 Loci

27/02/2015

Omixon announce that Holotype HLA™, a HLA genotyping product that is NGS-based and provides the most complete and accurate characterization of the HLA genes, will be extended from five to seven HLA loci. Launched with five loci (HLA-A, B, C, DRB1, DQB1) in October 2014, and currently available under...